Vaxcyte
PCVX
$68.70
Share price
-0.09%
Change (1 day)
40.29%
Change (1 year)
Categories
Vaxcyte (PCVX) - Cash on Hand
Cash on Hand as of March 2024 : $1.48 B
According to Vaxcyte
's latest financial reports the company has $1.48 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vaxcyte - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.08 B | 15.98% |
| 2022-12-31 | $0.93 B | 278.65% |
| 2021-12-31 | $0.24 B | -36.31% |
| 2020-12-31 | $0.38 B | 554.84% |
| 2019-12-31 | $58.97 M | -10.76% |
| 2018-12-31 | $66.09 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | -78.69% | 🇺🇸 USA |